Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-04-09

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, indicating changes related to labeling or related manufacturing details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)